Local RAS

Advances in Experimental Medicine and Biology

Volumn 690, Issue , 2010, Pages 69-87

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 4 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II [3-8]; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLUCOSE TRANSPORTER 5; INSULIN; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RENIN; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 2; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; AUTOCRINE EFFECT; CAROTID BODY CHEMORECEPTOR; CHANNEL GATING; CONGESTIVE HEART FAILURE; DISEASE MODEL; ELECTROLYTE BALANCE; FLUID BALANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPOXIA; INTESTINE CELL; LIVER CIRRHOSIS; LIVER FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; ANIMAL; CAROTID BODY; INTESTINE; LIVER; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; CAROTID BODY; HUMANS; INTESTINES; LIVER; RENIN-ANGIOTENSIN SYSTEM;

EID: 79956220706     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-90-481-9060-7_5     Document Type: Article

References (78)

1. Albiston AL, McDowall SG, Matsacos D, Simpson RJ, Connolly LM and Chai SY. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 276:48623-48626, 2001.
2. Alison MR. Regulation of hepatic growth. Physiol Rev 66:499-451, 1986.
3. Allen AM. Angitoensin AT1receptor-mediated excitation of rat carotid body chemoreceptor afferent activity. J Physiol 510:773-781, 1998. (Pubitemid 28401284)
4. Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-Lopez F and Rodes J. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites. Eur J Clin Invest 11:221-229, 1981. (Pubitemid 11002897)
5. Atzori L, Poli G and Perra A. Hepatic stellate cell: A star cell in the liver. Int J Biochem Cell Biol 41:1639-1642, 2009.
6. Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V and Rodes J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118:1149-1156, 2000. (Pubitemid 30346992)
7. Bindom SM and Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 302:193-202, 2009.
8. Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'? Br J Nutr 79:315-327, 1998. (Pubitemid 28163893)
9. Burant CF, Flink S, DePaoli AM, Chen J, Lee WS and Chang EB. Small intestinal hexose transport in experimental diabetes: increased transporter mRNA and protein expression in enterocytes. J Clin Invest 93:578-585, 1994.
10. Burgess ED, Hawkins RG and Watanabe M. Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens 3:903-905, 1990.
11. Casini A. Alcohol-induced fatty liver and inflammation: where do Kupffer cells act? J Hepatol 32:1026-1030, 2000. (Pubitemid 30368097)
12. Chan H, Leung PS and Tam SC. Effect of angiotensin AT1receptor antagonist on D-galactosamineinduced acute liver injury. Clin Exp Pharmacol Physiol 34:985-991, 2007. (Pubitemid 47274550)
13. Cheeseman CI. Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol 273:R1965-R1971, 1997.
14. Cheeseman CI and Tsang R. The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport. Am J Physiol 271:G477-G482, 1996.
15. Debnam ES, SmithMW, Sharp PA, Srai SK, Turvey A and Keable SJ. The effects of streptozotocin diabetes on sodium-glucose transporter (SGLT1) expression and function in rat jejunal and ileal villus-attached enterocytes. Eur J Physiol 430:151-159, 1995.
16. Debnam ES and Sharp PA. Acute and chronic effects of pancreatic glucagon on sugar transport across the brush-border and basolateral membranes of rat jejunal enterocytes. Exp Physiol 78:197-207, 1993. (Pubitemid 23135265)
17. Debnam ES, Karasov WH and Thompson CS. Nutrient uptake by rat enterocytes during diabetes mellitus: evidence for an increased sodium electrochemical gradient. J Physiol 397: 503-512, 1988. (Pubitemid 18062587)
18. Ducroc R, Guilmeau S, Akasbi K, Devaud H, Buyse M and Bado A. Luminal leptin induces rapid inhibition of active intestinal absorption of glucose mediated by sodium-glucose cotransporter 1. Diabetes 54:348-354, 2005.
19. Erickson RH, Suzuki Y, Sedlmayer A, Song IS and Kim YS. Rat intestinal angiotensin-converting enzyme: purification, properties, expression, and function. Am J Physiol 263:466-473, 1992.
20. Fung ML, Lam SY, Wong TP, Tjong YW and Leung PS. Carotid body AT4 receptor expression and its upregulation in chronic hypoxia. Open Cardiovasc Med J 1:1-7, 2007.
21. 1a angiotensin receptors in rat carotid body chemoreceptors. J Endocrinol 173:305-313, 2002. (Pubitemid 34552459)
22. Fung ML, Lam SY, Dong X, Chen Y and Leung PS. Functional expression of angiotensin II receptors in type-I cells of the rat carotid body. Eur J Endocrinol 441:474-480, 2001. (Pubitemid 32128142)
23. Gascon-Barre M, Demers C, Mirshahi A, Neron S, Zaizal S and Nanci A. The normal liver harbors the vitamin D nuclear receptor in non-parenchymal and biliary epithelial cells. Hepatology 37:1034-1042, 2003. (Pubitemid 36538680)
24. Gonzalez C, Almaraz L, Obeso A and Rigual R. Carotid body chemoreceptors: from natural stimuli to sensory discharges. Physiol Rev 74:829-898, 1994. (Pubitemid 24328941)
25. Hardikar W and Suchy FJ. Hepatobiliary function. In Boron WF and Boulpaep EL (eds), Medical physiology, pp 975-1002, Saunders, New York, NY, 2003.
26. Harrison SA. New treatments for nonalcoholic fatty liver disease. Curr Gastroenterol Rep 8: 21-29, 2006.
27. Herath CB, Warner FJ, Lubel JS, Dean RG, Jia Z, Lew RA, Smith AI, Burrell LM and Angus PW. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol 47:387-395, 2007. (Pubitemid 47176156)
28. Hirose A, Ono M, Saibara T, Nozaki Y, Masuda K, Yoshioka A, Takahashi M, Akisawa N, Iwasaki S, Oben JA and Onishi S. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 45(6):1375-1381, 2007. (Pubitemid 46918321)
29. Hollis BW. 25-Hydroxyvitamin D3-1 alpha-hydroxylase in porcine hepatic tissue: subcellular localization to both mitochondria and microsomes. Proc Natl Acad Sci USA 87: 6009-6013, 1990.
30. Hopfer U. Diabetes mellitus: changes in the transport properties of isolated intestinal microvillous membranes. Proc Nat Acad Sci USA 72:2027-2031, 1975.
31. Iwai M and Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res 32: 533-536, 2009.
32. Jin XH, Wang ZQ, Siragy HM, Guerrant RL and Carey RM. Regulation of jejunal sodium and water absorption by angiotensin subtype receptors. Am J Physiol 275:R515-R523, 1998.
33. +/glucose cotransporter SGLT2. J Clin Invest 93:397-404, 1994.
34. Kawano K, Ikari A, Nakano M and Suketa Y. Phosphatidylinositol 3-kinase mediates inhibitory effect of angiotensin II on sodium/glucose cotransporter in renal epithelial cells. Life Sci 71: 1-13, 2002. (Pubitemid 34520463)
35. Kellett GL, Brot-Laroche E, Mace OJ and Leturque A. Sugar absorption in the intestine: the role of GLUT2. Ann Rev Nutr 28:1-20, 2008.
36. Kellett GL and Brot-Laroche E. Apical GLUT2: A major pathway of intestinal sugar absorption. Diabetes 54:3056-3062, 2005. (Pubitemid 41401109)
37. Kellett GL. The facilitated component of intestinal glucose absorption. J Physiol 531:585-595, 2001. (Pubitemid 32243741)
38. Kong J and Li YC. Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice. Am J Physiol 285:R255-R261, 2003. (Pubitemid 36736524)
39. Lam SY, Fung ML and Leung PS. Regulation of the angiotensin-converting enzyme activity by a time-course hypoxia in the carotid body. J Appl Physiol 96:809-813, 2004. (Pubitemid 38140191)
40. Lam SY and Leung PS. Chronic hypoxia activates a local angiotensin-generating system in rat carotid body. Mol Cell Endocrinol 203:147-153, 2003. (Pubitemid 36627595)
41. Lam SY and Leung PS. A locally generated angiotensin system in rat carotid body. Regul Pept 107:97-103, 2002. (Pubitemid 34876450)
42. Lavoie JL and Sigmund CD. Overview of the renin-angiotensin system: An endocrine and paracrine system. Endocrinology 144:2179-2183, 2003. (Pubitemid 36629863)
43. Leung PS. Angiotensin II and intestinal glucose uptake. Physiol News 72:PN21, 2008 www.physoc.org.
44. Leung PS. The physiology of a local renin-angiotensin system in the pancreas. J Physiol 580: 31-37, 2007. (Pubitemid 46470642)
45. Leung PS. Novel roles of a local angiotensin-generating system in the carotid body. J Physiol 575:4, 2006. (Pubitemid 44178124)
46. Leung PS. The peptide hormone angiotensin II: its new functions in tissues and organs. Curr Protein Pept Sci 5:267-273, 2004.
47. Leung PS, Fung ML and Tam MS. Renin-angiotensin system in the carotid body. Int J Biochem Cell Biol 35(6):847-854, 2003. (Pubitemid 36379326)
48. Leung PS, Lam SY and Fung ML. Chronic hypoxia upregulates the expression and function of AT1 receptor in rat carotid body. J Endocrinol 167:517-524, 2000. (Pubitemid 32047559)
49. Li YC, Kong J, Wei M, Chen ZF, Liu SQ and Cao LP. 1,25-Dihydroxyvitamin D(3) is a negativeendocrine regulator of the renin-angiotensin system. J Clin Invest 110:229-238, 2002. (Pubitemid 34787360)
50. Li Y and Schultz HD. Enhanced sensitivity of Kv channels to hypoxia in the rabbit carotid body in heart failure: role of angiotensin II. J Physiol 575:215-227, 2006. (Pubitemid 44178139)
51. Lind L, Hanni A, Lithell H, Hvarfner A, Sorensen OH and Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8:894-901, 1995.
52. Lubel JS, Herath CB, Tchongue J, Grace J, Jia Z, Spencer K, Casley D, Crowley P, Sievert W, Burrell LM and Angus PW. Angioensin-(1-7), an alternative metabolite of the reninangiotensin system, is up-regulated in human liver disease and has anti-fibrotic activity in the bile-duct-ligated rat. Clin Sci 117:375-386, 2009.
53. Lubel JS, Herath CB, Burrell LM and Angus PW. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications. J Gastroenterol Hepatol 23:1327-1338, 2008.
54. Naim HY. Angiotensin-converting enzyme of the human small intestine. Subunit and quaternary structure, biosynthesis and membrane association. Biochem J 286:451-457, 1992.
55. Paizis G, Tikellis C, Cooper ME, Schembri JM, Lew RA, Smith AI, Shaw T, Warner FJ, Zuilli A, Burrell LM and Angus PW. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54:1790-1796, 2005. (Pubitemid 41697680)
56. +/glucose cotransporters. Biochem Biophys Acta 1106:216-220, 1992.
57. Park SH and Han HJ. The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells. Am J Physiol 282:F228-F237, 2001.
58. Park SH, Woo CH, Kim JH, Lee JH, Yang IS, Park KM and Han HJ. High glucose down-regulates angiotensin II binding via PKC-MAPK-cPLA2 signal cascade in renal proximal tubule cells. Kidney Int 61:913-925, 2002.
59. Paul M, Mehr AP and Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86:747-803, 2006. (Pubitemid 44033382)
60. Pennington AM, Corpe CP and Kellett GL. Rapid regulation of rat jejunal glucose transport by insulin in a luminally and vascularly perfused preparation. J Physiol 478:187-193, 1994. (Pubitemid 24232191)
61. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21:49-98, 2000. (Pubitemid 30642764)
62. Ren X, Glende J, Al-Falah M, de Vries V, Schwegmann-Wessels C, Qu X. Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J Gen Virol 87:1691-1695, 2006. (Pubitemid 43827224)
63. Rockey DC and Weisiger RA. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 24:233-240, 1996. (Pubitemid 26249439)
64. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A and Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 21:1-26, 2005. (Pubitemid 40767684)
65. Santos RA, Ferreira AJ, Simoes E and Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 93:519-527, 2008. (Pubitemid 351595060)
66. Schneider AW, Kalk JF and Klein CP. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 29:334-339, 1999. (Pubitemid 29088434)
67. Seo MS, Fukamizu A, Saito T and Murakami K. Identification of a previously unrecognized production site of human renin. Biochim Biophys Acta 1129:87-89, 1991.
68. Stevens BR, Fernandez A, Kneer C, Cerda JJ, Phillips MI and Woodward ER. Human intestinal brush border angiotensin-converting enzyme activity and its inhibition by antihypertensive Ramipril. Gastroenterology 94:942-947, 1988.
69. Targher G, Bertolini L, Scala L, Ciglioni M, Zenari L, Falezza G and Arcaro G. Associations between serum 25-hydroxyvitamiun D3 concentrations and liver histology in patients with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17:517-524, 2007. (Pubitemid 47176859)
70. Wang TT, Tavera-Mendoza LE, Lapierre D, Libby E, Burton MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B and Zhang R. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 19:2685-2895, 2005.
71. Wong TP, Debnam ES and Leung PS. Diabetes mellitus and expression of the enterocyte reninangiotensin system: implications for control of glucose transport across the brush border membrane. Am J Physiol 297:C601-C610, 2009.
72. Wong TP, Debnam ES and Leung PS. Involvement of an enterocyte renin-angiotensin system in the local control of SGLT1-dependent glucose uptake across the rat small intestinal brush border membrane. J Physiol 584:613-623, 2007. (Pubitemid 47578343)
73. Woo J, Lam CW, Leung J, Lau WY, Lau E, Ling X, Xing X, Zhao XH, Skeaff CM, Bacon CJ, Rockell JE, Lambert A,Whiting SJ and Green TJ. Very high rates of vitamin D insufficiency in women of child-bearing age living in Beijing and Hong Kong. Br J Nutr 99:1330-1334, 2008.
74. Wright EM, Hirayama BA and Loo DF. Active sugar transport in health and disease. J Int Med 261:32-43, 2006.
75. +/glucose cotransporters (SLC5). Physiology 19:370-376, 2004. (Pubitemid 39636085)
76. Wright EM, Hirayama BA, Loo DDF, Turk E and Hager K. Intestinal sugar transport. In LR Johnson (ed), Physiology of the gastrointestinal tract, 3rd edn. Raven Press, New York, NY, pp 1751-1772, 1994.
77. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H and Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34:745-750, 2001. (Pubitemid 32927999)
78. Yoshioka M, Erickson RH,Woodley JF, Gulli R, Guan D and Kim YS. Role of rat intestinal brushborder membrane angiotensin-converting enzyme in dietary protein digestion. Am J Physiol 253:G781-G786, 1987.